• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫颈癌:CT与MR表现的比较

Uterine cervical carcinoma: comparison of CT and MR findings.

作者信息

Kim S H, Choi B I, Lee H P, Kang S B, Choi Y M, Han M C, Kim C W

机构信息

Department of Radiology, College of Medicine, Seoul National University Hospital, Republic of Korea.

出版信息

Radiology. 1990 Apr;175(1):45-51. doi: 10.1148/radiology.175.1.2315503.

DOI:10.1148/radiology.175.1.2315503
PMID:2315503
Abstract

Thirty patients with uterine cervical carcinoma underwent computed tomography (CT), magnetic resonance (MR) imaging, and surgical exploration. MR imaging was superior to CT in visualization of the tumor. MR imaging had an accuracy of 77% in the assessment of thickness of cervical stromal invasion. The accuracy rates of these modalities for parametrial evaluation were 78% for clinical evaluation, 70% for CT, and 92% for MR imaging. The overall accuracy rates for tumor staging were 70% for clinical evaluation, 63% for CT, and 83% for MR imaging. MR imaging is superior to clinical evaluation and CT in parametrial evaluation and the staging of uterine cervical carcinoma.

摘要

30例子宫颈癌患者接受了计算机断层扫描(CT)、磁共振(MR)成像及手术探查。在肿瘤可视化方面,MR成像优于CT。MR成像在评估宫颈基质浸润深度方面的准确率为77%。这些检查方式用于宫旁组织评估的准确率分别为:临床评估78%、CT 70%、MR成像92%。肿瘤分期的总体准确率分别为:临床评估70%、CT 63%、MR成像83%。在子宫颈癌的宫旁组织评估及分期方面,MR成像优于临床评估和CT。

相似文献

1
Uterine cervical carcinoma: comparison of CT and MR findings.子宫颈癌:CT与MR表现的比较
Radiology. 1990 Apr;175(1):45-51. doi: 10.1148/radiology.175.1.2315503.
2
Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients.子宫颈癌的术前分期:99例患者CT与MRI的比较
J Comput Assist Tomogr. 1993 Jul-Aug;17(4):633-40. doi: 10.1097/00004728-199307000-00022.
3
Cervical carcinoma with full-thickness stromal invasion: efficacy of dynamic MR imaging in the assessment of parametrial involvement.伴有全层间质浸润的宫颈癌:动态磁共振成像在评估宫旁组织受累中的效能
Radiat Med. 2002 Sep-Oct;20(5):247-55.
4
Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma.动态螺旋CT与动态磁共振成像在宫颈癌盆腔淋巴结评估中的比较
AJR Am J Roentgenol. 2000 Sep;175(3):759-66. doi: 10.2214/ajr.175.3.1750759.
5
[Invasive carcinoma of the cervix uteri (Stage IB-IIB). Comparison of CT and MR for the assessment of the parametrium].子宫颈浸润癌(IB-IIB期)。CT与MR对子宫旁组织评估的比较
Radiol Med. 1991 May;81(5):671-7.
6
CT and ultra low field (0.02 T) MR imaging of uterine cervical carcinoma.子宫颈癌的CT及超低场(0.02T)磁共振成像
Acta Radiol. 1994 Jul;35(4):361-6.
7
Carcinoma of the cervix: staging with MR imaging.子宫颈癌:磁共振成像分期
Radiology. 1989 Apr;171(1):245-51. doi: 10.1148/radiology.171.1.2928532.
8
Staging of cervical cancer: comparison between magnetic resonance imaging, computed tomography and pelvic examination under anesthesia.宫颈癌分期:磁共振成像、计算机断层扫描与麻醉下盆腔检查的比较
J Formos Med Assoc. 1992 Oct;91(10):982-90.
9
Comparison of the use of the transrectal surface coil and the pelvic phased-array coil in MR imaging for preoperative evaluation of uterine cervical carcinoma.经直肠表面线圈与盆腔相控阵线圈在磁共振成像中用于子宫颈癌术前评估的比较。
AJR Am J Roentgenol. 1997 May;168(5):1215-21. doi: 10.2214/ajr.168.5.9129414.
10
Carcinoma of the cervix: value of MR imaging in detecting parametrial involvement.子宫颈癌:磁共振成像在检测宫旁组织受累中的价值。
AJR Am J Roentgenol. 1991 Apr;156(4):753-6. doi: 10.2214/ajr.156.4.2003441.

引用本文的文献

1
Diagnostic Imaging Performance of Dual-Energy Computed Tomography Compared with Conventional Computed Tomography and Magnetic Resonance Imaging for Uterine Cervical Cancer.双能计算机断层扫描与传统计算机断层扫描及磁共振成像在子宫颈癌诊断成像中的性能比较
Indian J Radiol Imaging. 2024 Jul 12;34(4):661-669. doi: 10.1055/s-0044-1787780. eCollection 2024 Oct.
2
Unclear tumor border in magnetic resonance imaging as a prognostic factor of squamous cell cervical cancer.磁共振成像中肿瘤边界不清作为宫颈鳞癌的预后因素。
Sci Rep. 2023 Sep 16;13(1):15392. doi: 10.1038/s41598-023-42787-7.
3
Prediction of Recurrent Cervical Cancer in 2-Year Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters: A Preliminary Study.
基于定量和定性磁共振成像参数对治疗后 2 年随访中复发性宫颈癌的预测:一项初步研究。
Ann Surg Oncol. 2023 Sep;30(9):5577-5585. doi: 10.1245/s10434-023-13756-1. Epub 2023 Jun 25.
4
Predictive Value of Inflammatory and Nutritional Indexes in the Pathology of Bladder Cancer Patients Treated with Radical Cystectomy.炎性和营养指标对接受根治性膀胱切除术的膀胱癌患者病理的预测价值。
Curr Oncol. 2023 Feb 21;30(3):2582-2597. doi: 10.3390/curroncol30030197.
5
Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.基于2018年国际妇产科联盟(FIGO)分期的诺模图预测接受根治性放疗的FIGO II至III期宫颈鳞状细胞癌患者的总生存期:一项回顾性分析
Cancer Manag Res. 2021 Dec 29;13:9391-9400. doi: 10.2147/CMAR.S336892. eCollection 2021.
6
Useful MRI Findings for Minimally Invasive Surgery for Early Cervical Cancer.早期宫颈癌微创手术的有用MRI表现。
Cancers (Basel). 2021 Aug 13;13(16):4078. doi: 10.3390/cancers13164078.
7
Implications of the new FIGO staging and the role of imaging in cervical cancer.FIGO 分期新系统的意义及影像学在宫颈癌中的作用。
Br J Radiol. 2021 Sep 1;94(1125):20201342. doi: 10.1259/bjr.20201342. Epub 2021 May 14.
8
Cervical Cancer Staging in Saudi Arabia Clinicoradiological Correlation.沙特阿拉伯临床与放射学相关性宫颈癌分期。
Biomed Res Int. 2019 Jun 23;2019:8745828. doi: 10.1155/2019/8745828. eCollection 2019.
9
Early Cervical Cancer: Predictive Relevance of Preoperative 3-Tesla Multiparametric Magnetic Resonance Imaging.早期宫颈癌:术前3特斯拉多参数磁共振成像的预测相关性
Int J Surg Oncol. 2018 Aug 1;2018:9120753. doi: 10.1155/2018/9120753. eCollection 2018.
10
A Network Meta-Analysis on the Diagnostic Value of Different Imaging Methods for Lymph Node Metastases in Patients With Cervical Cancer.不同成像方法对宫颈癌患者淋巴结转移诊断价值的网状Meta分析
Technol Cancer Res Treat. 2018 Jan 1;17:1533034617742311. doi: 10.1177/1533034617742311.